Latest Period
Q2 2026
Security Snapshot
Entera Bio Ltd. - Ordinary Shares, par value per share NIS 0.0000769 (ENTX) Institutional Ownership
CUSIP: M40527109
13F Institutional Holders and Ownership History from Q2 2018 to Q2 2026
Institutions Reporting
27
Shares (Excl. Options)
10,728,883
Price
$1.77
Save this security page for your next review
Keep this CUSIP in your watchlists so you can revisit quarter changes from one place. If you create an account from here, we will bring you back after verification.
- Security type / class
- Equity / Ordinary Shares, par value per share NIS 0.0000769
- Symbol
- ENTX on Nasdaq
- All holders as of 30 Jun 2026
- Q2 2026
- Total 13F shares
- 10,728,883
- Total 13F value
- $18,985,880
- Portfolio coverage rank
- 0%
- Share change
- +2,856,700
- Value change
- +$5,294,822
- Number of holders
- 27
- Shares outstanding
- 170,503,000
- SEC-reported price per share
- $2.95
- Insider filing price
- $2.95
Latest holder snapshot
5 signals
Issuer context
Names, identifiers, and filing context for this profile.
3 identity fields
13F Shares, Excluding Options vs Price
13F Value, Excluding Options
Total Investors
Key facts
- ENTX - Entera Bio Ltd. - Ordinary Shares, par value per share NIS 0.0000769 is tracked under CUSIP M40527109.
- 27 institutions reported positions in Q2 2026.
- 7 significant owners is listed from Schedule 13D/13G reporting.
Change
- Holder count moved from 26 to 27 between Q1 2026 and Q2 2026.
- SEC-reported value moved from $8,677,875 to $18,985,880.
Research use
- You can quickly see who holds this security, then open quarter and manager detail pages for full evidence.
- 13F and Schedule 13D/13G sections are kept together so you can cross-check institutional and beneficial ownership context.
Evidence
Source: SEC Form 13F
Open SEC evidence
Latest holder context comes from 27 institutions filings for Q2 2026.
Security key
M40527109
Latest holder period
Q2 2026
13F holders
27
13D/G owners
7
CIK / CUSIP context first
Open Q2 2026 holders
ENTX full holder history
Entera Bio Ltd. SEC filings
Entera Bio Ltd. company facts
Entera Bio Ltd. insider transactions
Broader feeds
Recent Quarterly Holder Reports
Open recent reporting periods for CUSIP M40527109:
13D/G owners
Significant owners
Large-stake holder rows connected to Schedule 13D/G evidence.
Rows
7
Security
ENTX
| Filer | Ownership | Change % | Holdings Value | Net Change | Nb Shares | Change % | Reporting Name | Report Period |
|---|---|---|---|---|---|---|---|---|
| BIOTECHNOLOGY VALUE FUND L P | 10% | $28,593,701 | 17,225,121 | BVF PARTNERS L P/IL | 28 Jul 2026 | |||
| TCG Crossover GP III, LLC | 7.1% | $20,343,136 | 12,254,901 | TCG Crossover GP III, LLC | 28 Jul 2026 | |||
| Vivo Opportunity Fund Holdings, L.P. | 6.9% | $19,616,886 | 11,817,401 | Vivo Opportunity, LLC | 28 Jul 2026 | |||
| Longitude Capital Partners V, LLC | 4.6% | $13,019,609 | 7,843,138 | Longitude Capital Partners V, LLC | 28 Jul 2026 | |||
| Seven Fleet Capital Management LP | 4.1% | $11,709,471 | 7,053,898 | Seven Fleet Capital Management LP | 28 Jul 2026 | |||
| OPKO HEALTH, INC. | 8.1% | $8,660,281 | 3,685,226 | OPKO HEALTH, INC. | 16 Mar 2025 | |||
| Point72 Asset Management, L.P. | 2.6% | -60% | $2,271,583 | -$2,915,412 | 1,183,116 | -56% | Point72 Asset Management, L.P. | 30 Sep 2025 |
As of 30 Jun 2026, 27 institutional investors reported holding 10,728,883 shares of Entera Bio Ltd. - Ordinary Shares, par value per share NIS 0.0000769 (ENTX). This represents 6.3% of the company’s total 170,503,000 outstanding shares.
Quarter history
Institutional holders across reporting periods
Holder count, reported shares/value, and median price by quarter.
Periods
33
Latest
Q2 2026
Rows shown
1-25 of 33
| Period | 13F Shares, Excl. Options | Value, Excl. Options | Value Change | Price (Median) | Investors |
|---|---|---|---|---|---|
| 2026 Q2 | 10,728,883 | $18,985,880 | +$5,294,822 | $1.77 | 27 |
| 2026 Q1 | 7,871,783 | $8,677,875 | -$1,722,017 | $1.11 | 26 |
| 2025 Q4 | 9,342,877 | $18,125,113 | +$502 | $1.94 | 22 |
| 2025 Q3 | 9,194,576 | $17,653,167 | -$1,951,360 | $1.92 | 21 |
| 2025 Q2 | 10,211,002 | $19,401,301 | +$12,863 | $1.90 | 19 |
| 2025 Q1 | 10,222,258 | $17,377,838 | +$4,637,662 | $1.70 | 18 |
| 2024 Q4 | 7,494,222 | $15,902,006 | +$4,661,706 | $2.12 | 14 |
| 2024 Q3 | 5,323,228 | $10,112,228 | +$57,454 | $1.90 | 17 |
| 2024 Q2 | 5,292,989 | $9,745,202 | +$1,916,835 | $1.84 | 14 |
| 2024 Q1 | 4,259,308 | $7,113,387 | +$404,057 | $1.67 | 14 |
| 2023 Q4 | 4,062,589 | $2,437,015 | +$887,868 | $0.60 | 9 |
| 2023 Q3 | 2,579,003 | $1,870,234 | +$4,206 | $0.72 | 11 |
| 2023 Q2 | 2,569,162 | $2,166,115 | -$314,934 | $0.84 | 10 |
| 2023 Q1 | 2,830,846 | $3,283,550 | -$215,433 | $1.16 | 8 |
| 2022 Q4 | 566,752 | $413,272 | -$1,176,817 | $0.73 | 10 |
| 2022 Q3 | 4,663,496 | $4,850,000 | -$254,655 | $1.04 | 8 |
| 2022 Q2 | 4,916,394 | $6,538,000 | -$45,964 | $1.33 | 9 |
| 2022 Q1 | 4,949,328 | $14,203,000 | -$2,021,499 | $2.86 | 10 |
| 2021 Q4 | 5,655,346 | $15,920,000 | -$38,159 | $2.82 | 10 |
| 2021 Q3 | 5,665,990 | $26,717,000 | +$2,489,496 | $4.71 | 13 |
| 2021 Q2 | 5,111,468 | $30,566,000 | +$18,924,636 | $5.98 | 14 |
| 2021 Q1 | 1,986,053 | $7,567,000 | +$563,572 | $3.81 | 7 |
| 2020 Q4 | 1,857,733 | $2,008,000 | -$82,677 | $1.09 | 5 |
| 2020 Q3 | 1,905,237 | $2,363,000 | -$160,746 | $1.24 | 5 |
| 2020 Q2 | 1,950,079 | $3,422,000 | -$82,244 | $1.83 | 5 |